Centrally-administered opioid selective agonists inhibit drinking in the rat.

Area of Science:

• Neuropharmacology
• Behavioral Neuroscience
• Physiology

Background:

• Opioid systems play a role in regulating fluid balance.
• Different opioid receptor subtypes (mu, kappa, delta) mediate distinct physiological effects.
• The specific role of endogenous dynorphin in water homeostasis remains to be fully elucidated.

Purpose of the Study:

• To investigate the effects of mu, kappa, and delta opioid agonists on water intake in water-deprived rats.
• To determine the rank order potency of various opioid agonists in influencing drinking behavior.
• To explore the potential role of endogenous dynorphin in the homeostatic control of water balance.

Main Methods:

• Intracerebroventricular injections of mu (morphine), kappa (dynorphin-(1-13), ethylketocyclazocine, U50,488H), and delta ([D-Pen2, D-Pen5]enkephalin) opioid agonists were administered to 14-hour water-deprived rats.
• Measurements included the time spent drinking and the latency to initiate drinking.
• Dose-response relationships were analyzed for each agonist.

Main Results:

• All tested opioid agonists significantly decreased the time spent drinking in a dose-dependent manner.
• The rank order of potency for decreasing drinking time was dynorphin-(1-13) > morphine > ethylketocyclazocine > [D-Pen2, D-Pen5]enkephalin = U50,488H.
• Dynorphin-(1-13) potently inhibited drinking at doses that did not affect the latency to drink, suggesting a specific role in water balance regulation.

Conclusions:

• Endogenous dynorphin likely plays a role in the homeostatic control of water balance.
• The potent effects of dynorphin-(1-13) on drinking may not be primarily mediated through kappa opioid receptors, as it was significantly more potent than selective kappa agonists.
• Further research is needed to fully understand the mechanisms underlying dynorphin's influence on water intake.